The Food and Drug Administration’s (FDA) vaccine advisory panel is set to meet Thursday and Friday, Oct. 14-15, over Moderna and Johnson & Johnson booster shots.
UPDATE: FDA advisory committee votes to approve Moderna vaccine booster shots for vulnerable groups
Recommended Videos
The FDA’s “Vaccines and Related Biological Products Advisory Committee” (VRBPAC) will discuss newly available data for the currently available COVID-19 vaccines. Here’s the meeting agenda for Oct. 14.
This meeting is considered the first step in the FDA’s decision process on whether extra doses of the two vaccines should be dispensed and, if so, who should get them and when. The final approval of an Emergency Use Authorization (EUA) is not expected for another week.
Related: Pfizer booster shots now available in Metro Detroit
The meeting starts at 8:30 a.m. Thursday with opening remarks by University of Michigan professor of public health and epidemiology Dr. Arnold Monto, M.D.
Watch it live right here:
Read more: Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines
COVID-19 Discussion Forum:
Join our dedicated space to discuss the pandemic. You’re invited to share questions, experiences, insights and opinions.